Era Mandiri Cemerlang Tbk PT (IKAN) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of Era Mandiri Cemerlang Tbk PT IDR 49, price IDR 90, upside -45.8%, quality 61 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Era Mandiri Cemerlang Tbk PT for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range 13.00 IDR – 242.00 IDR · fair‑value band 43.30 IDR – 53.47 IDR · the 90.00 IDR price screens above the 48.82 IDR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Era Mandiri Cemerlang Tbk PT in your weekly email
Every Wednesday you see whether Era Mandiri Cemerlang Tbk PT is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
PT Era Mandiri Cemerlang Tbk produces and supplies seafood products in Indonesia and internationally.
Show more
PT Era Mandiri Cemerlang Tbk produces and supplies seafood products in Indonesia and internationally. The company offers yellowfin tuna, bigeye tuna, oilfish, swordfish, black pomfret, Spanish mackerel, shark, red snapper, bullet tuna, skipjack tuna, wahoo, goldband snapper, leather jacket, emperor, parrotfish, mahi-mahi, grouper, milkfish, and other fish products; squid products; and octopus products. It exports its products to the United States, Mexico, Ecuador, Germany, the Netherlands, Poland, Portugal, Hong Kong, China, India, the Philippines, and various Middle Eastern countries. PT Era Mandiri Cemerlang Tbk was founded in 2000 and is headquartered in Jakarta Utara, Indonesia.
Stock analysis
Era Mandiri Cemerlang Tbk PT (IKAN) currently trades at 90.00 IDR, while our model-based Fair Value estimate is 48.82 IDR, implying the stock looks roughly 84.4% overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 134.47 IDR per share, and 10 of the 23 models we run sit above the 90.00 IDR price.
Bear case: the Earnings-Based group reads lowest at 11.37 IDR, and 13 of the 23 models stay below the price. Evidence for this calculation is low.
Scenario range: 43.30 IDR (bear) to 53.47 IDR (bull), the price of 90.00 IDR sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 61/100 (solid quality), in the Consumer Defensive sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Era Mandiri Cemerlang Tbk PT reported revenue of 123B IDR in FY2025 versus 111B IDR in FY2021, a compound +2.4%/yr. Reported net income was 557M IDR in FY2025, compounding −23.2%/yr from FY2021.
Key figures
Market cap 75.0B IDR (≈ $4.2M) · P/E ratio 45.9 · P/S ratio 0.21 · EPS (TTM) 1.96 IDR · Net margin 0.5% · Return on equity −0.6% · Return on assets (EBIT) 3.2% · Operating margin 0.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).
What moves the price
The share trades about 38% below its 52-week high and 43% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at 10% fair-value upside, at −46%, IKAN screens richer than that median.
Fair Value models
Bear 43.30 IDRFair Value 48.82 IDRBull 53.47 IDR
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (1.44 IDR per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.70/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+5.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.7%
Start year 2020 (pandemic)
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.1%
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in IDR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis. Measured in IDR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−5.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year−5.4%
Dividend (yield on the price)0.0%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.5% → 3%
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−4.6%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Indonesia: IMF forecast 2.6% a year to 2030, 2.9% from 2016 to 2025) that is about −7.0% a year for the price.
Compare Era Mandiri Cemerlang Tbk PT with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Farm Products · 296 stocks
Beats the industry median on 3/9 measures
Overall it trails its industry peers.
Valuation
Quality Score61 · Above median
Fair Value upside−46% · Bottom 25%
Profitability
Return on assets1% · Below median
Net margin (TTM)0% · Below median
Operating margin (TTM)1% · Below median
Growth and dividend
Revenue growth−12% · Bottom 25%
Balance sheet
Debt / equity0.02× · Lowest 25%
Valuation Multiplesvs Farm Products median · lower = cheaper
P/E (TTM)45.9× · Priciest 25%
P/FCF0.0× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 26
FUTURE (revenue growth)0· sector 21
PAST (return on equity)0· sector 19
HEALTH (low debt)99· sector 94
DIVIDEND (yield)0· sector 47
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Era Mandiri Cemerlang Tbk PT (IKAN) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 48.82 IDR versus a price of 90.00 IDR, about −46% upside (overvalued).
What is the fair value of IKAN?
Our model-based fair value for Era Mandiri Cemerlang Tbk PT is 48.82 IDR (as of Sep 24, 2026), built from audited fundamentals. The current price: 90.00 IDR.
What is the quality score of IKAN?
Era Mandiri Cemerlang Tbk PT has a Quality Score of 61/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Era Mandiri Cemerlang Tbk PT (IKAN)?
Our model-based price target is the fair value of 48.82 IDR (as of Sep 24, 2026) from 23 valuation models. Cautious scenario 43.30 IDR, optimistic scenario 53.47 IDR. It is a calculation from audited fundamentals, not an analyst target.
What is the Era Mandiri Cemerlang Tbk PT stock forecast for 2026?
Our models put fair value at 48.82 IDR, about −46% upside versus a price of 90.00 IDR (overvalued). Cautious scenario 43.30 IDR, optimistic scenario 53.47 IDR. The calculation is refreshed regularly with new filings.
What is the revenue of Era Mandiri Cemerlang Tbk PT (IKAN)?
Era Mandiri Cemerlang Tbk PT reported trailing-twelve-month revenue of about 119B IDR (latest available figure, as of Sep 24, 2026).
What growth is priced into Era Mandiri Cemerlang Tbk PT (IKAN)?
For today's price to be fair in a discounted-cash-flow model, Era Mandiri Cemerlang Tbk PT would have to grow free cash flow by -4.6 % per year for five years (discount rate 10.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +7.7 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of IKAN use?
Our models discount Era Mandiri Cemerlang Tbk PT at 10.5 %: a base by market capitalisation (nano), damped by beta 0.09, country premium for Indonesia. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Era Mandiri Cemerlang Tbk PT that is -4.6 % per year a year over ten years, using the same discount rate (10.5 %) and the same formula as our fair value.
How much growth has Era Mandiri Cemerlang Tbk PT (IKAN) delivered so far?
Over the past 5 years revenue at Era Mandiri Cemerlang Tbk PT grew +7.7 % a year. The price currently implies -4.6 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Era Mandiri Cemerlang Tbk PT (IKAN) growing?
The median revenue growth in the sector is +2.9 % a year. That is the yardstick for the growth priced into Era Mandiri Cemerlang Tbk PT (-4.6 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Era Mandiri Cemerlang Tbk PT (IKAN)?
The free-cash-flow yield on the price is 11.39 %: that much free cash flow Era Mandiri Cemerlang Tbk PT produces per unit of market value. When it exceeds the discount rate of our models (10.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Era Mandiri Cemerlang Tbk PT (IKAN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Era Mandiri Cemerlang Tbk PT it is 48.82 IDR per share (as of Sep 24, 2026), against a price of 90.00 IDR. It is the blended result of 23 valuation models (cash flow, earnings, asset, dividend).
Is Era Mandiri Cemerlang Tbk PT stock overvalued or undervalued in 2026?
As of Sep 24, 2026, IKAN trades above its calculated fair value: price 90.00 IDR, fair value 48.82 IDR, a gap of about −46% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of IKAN?
No. The price is what the market pays today (90.00 IDR); the fair value is what the company's own numbers justify (48.82 IDR). For Era Mandiri Cemerlang Tbk PT the two are 41.18 IDR per share apart. That gap is exactly why we show both numbers side by side.
How much is Era Mandiri Cemerlang Tbk PT worth?
The market values Era Mandiri Cemerlang Tbk PT at about 75.0B IDR (market capitalisation, as of Sep 24, 2026). Per share that is 90.00 IDR; our models calculate a fair value of 48.82 IDR per share.
What do the bullish and bearish scenarios say about IKAN?
Our models span a range for Era Mandiri Cemerlang Tbk PT: cautious scenario 43.30 IDR, base 48.82 IDR, optimistic 53.47 IDR per share (as of Sep 24, 2026, price 90.00 IDR). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of IKAN?
Era Mandiri Cemerlang Tbk PT trades at a price-to-earnings ratio of 45.9 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 48.82 IDR is built from several models across several years.
How solid is the balance sheet of Era Mandiri Cemerlang Tbk PT (IKAN)?
Balance-sheet figures for Era Mandiri Cemerlang Tbk PT (as of Sep 24, 2026): return on equity −0.6%, debt of 0.02 per unit of equity. They feed the Quality Score of 61/100, which measures business quality independently of the share price.
How far is IKAN from its 52-week high?
Era Mandiri Cemerlang Tbk PT trades at 90.00 IDR, about 38% below its 52-week high of 146.00 IDR and 43% above the low of 63.00 IDR (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 48.82 IDR is for.
Which stocks are comparable to Era Mandiri Cemerlang Tbk PT?
From the same area (Consumer Defensive) we also value Archer-Daniels-Midland Company, Muyuan Foods Group, Bunge Global SA, Tyson Foods, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Era Mandiri Cemerlang Tbk PT stock attractive at the current price?
The data as of Sep 24, 2026: price 90.00 IDR, calculated fair value 48.82 IDR (−46%), Quality Score 61/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of IKAN calculated?
We run Era Mandiri Cemerlang Tbk PT through 23 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 48.82 IDR, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Era Mandiri Cemerlang Tbk PT itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Era Mandiri Cemerlang Tbk PT (IKAN)?
The closing price on Sep 24, 2026 was 90.00 IDR. Our model-based fair value is 48.82 IDR, about −46% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Era Mandiri Cemerlang Tbk PT right now?
The price sits above even our optimistic bull case (53.47 IDR). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (61/100) and above fair value, neither a clear bargain nor a standout compounder.
Key figures of Era Mandiri Cemerlang Tbk PT
How large is the market capitalisation of Era Mandiri Cemerlang Tbk PT (IKAN)?
The market capitalisation of Era Mandiri Cemerlang Tbk PT is 75.0B IDR (≈ $4.2M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Era Mandiri Cemerlang Tbk PT (IKAN)?
The price-to-sales ratio of Era Mandiri Cemerlang Tbk PT is 0.21 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Era Mandiri Cemerlang Tbk PT (IKAN)?
Earnings per share at Era Mandiri Cemerlang Tbk PT are 1.96 IDR (price ÷ EPS = P/E 45.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Era Mandiri Cemerlang Tbk PT (IKAN)?
The net margin of Era Mandiri Cemerlang Tbk PT is 0.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Era Mandiri Cemerlang Tbk PT (IKAN)?
The return on equity (ROE) of Era Mandiri Cemerlang Tbk PT is −0.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Era Mandiri Cemerlang Tbk PT (IKAN)?
On an EBIT basis the return on assets of Era Mandiri Cemerlang Tbk PT is 3.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Era Mandiri Cemerlang Tbk PT (IKAN)?
The operating margin of Era Mandiri Cemerlang Tbk PT is 0.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Era Mandiri Cemerlang Tbk PT (IKAN)?
Revenue at Era Mandiri Cemerlang Tbk PT is growing −12.1% versus a year earlier (3y avg +2.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Era Mandiri Cemerlang Tbk PT (IKAN)?
Earnings per share at Era Mandiri Cemerlang Tbk PT are growing −87.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Era Mandiri Cemerlang Tbk PT (IKAN) carry?
The net debt of Era Mandiri Cemerlang Tbk PT is 41.2B IDR (fiscal year 2025, ≈ 4.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Era Mandiri Cemerlang Tbk PT in the live analysis
One click puts Era Mandiri Cemerlang Tbk PT on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
